Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT00696592
Eligibility Criteria:
Inclusion Criteria:
* All lesion subtype of CNV secondary to age-related macular.
* sub-foveal CNV.
* patients who fail to respond to Photodynamic therapy.
* patients who are not eligible for PDT (Greatest linear dimension of the lesion \>/= 5400 um, CNV with hemorrhage \>/= 50 % of the entire lesion, minimally classic or occult CNV with greatest linear dimension of the lesion \>/= 4600 um.).
* Patients affected by Pigment Epithelium Detachment with CNV.
* Patients affected by Retinal Angiomatous Proliferation.
* Willingness and ability to participate and provide written informed consent.
Exclusion Criteria:
* Individuals with choroidal neovascularization from causes other than AMD (Myopia, Angioid Streaks).
* Any intraocular surgery within 2 months in the study eye.
* Prior retinal or vitreous surgery including posterior segment vitrectomy or scleral buckling in the study eye.
* Any significant ocular disease that has compromised or could compromise vision in the study eye.
* Prior stroke, myocardial infarction, or end-stage malignancy.
* Active hepatitis or clinically significant liver disease, renal failure.
* Any patient with recent history of new onset cardiac disease or thromboembolic CNS event in the past.
* Patients who are in an experimental therapy study or who have received experimental therapy within the last 12 weeks.
* Patients who are a poor medical risk because of other systemic diseases or active uncontrolled infections.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
80 Years
Study:
NCT00696592
Study Brief:
Protocol Section:
NCT00696592